Lapides Asset Management, LLC - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 58 filers reported holding PSYCHEMEDICS CORP in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Lapides Asset Management, LLC ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q3 2021$137,000
+18.1%
16,300
-2.4%
0.06%
+23.9%
Q2 2021$116,000
-12.1%
16,700
-21.6%
0.05%
-16.4%
Q1 2021$132,000
+112.9%
21,300
+74.6%
0.06%
+103.7%
Q4 2020$62,000
-39.2%
12,200
-47.4%
0.03%
-51.8%
Q3 2020$102,000
-1.0%
23,200
+24.7%
0.06%
-6.7%
Q2 2020$103,000
-52.1%
18,600
+73.8%
0.06%
+50.0%
Q1 2017$215,000
+87.0%
10,700
-5.3%
0.04%
+100.0%
Q4 2015$115,000
+3.6%
11,300
+2.7%
0.02%
+5.3%
Q3 2015$111,00011,0000.02%
Other shareholders
PSYCHEMEDICS CORP shareholders Q2 2017
NameSharesValueWeighting ↓
Tieton Capital Management, LLC 285,903$5,878,0005.05%
Moors & Cabot, Inc. 373,296$7,670,0001.02%
Gs Investments, Inc. 15,500$318,680,0000.24%
QUANTUM CAPITAL MANAGEMENT 47,205$971,0000.23%
North Star Investment Management Corp. 81,150$1,668,0000.20%
RBF Capital, LLC 78,495$1,614,0000.18%
Uniplan Investment Counsel, Inc. 196,882$4,047,0000.16%
CRAWFORD INVESTMENT COUNSEL INC 230,685$4,743,0000.15%
Granite Investment Partners, LLC 67,501$1,388,0000.09%
Municipal Employees' Retirement System of Michigan 58,900$1,211,0000.06%
View complete list of PSYCHEMEDICS CORP shareholders